$CSW

CSW (NYSE:CSW) Beats Q2 CY2026 Sales Expectations

CSW (NYSE: CSW) reported Q2 CY2026 revenue of $350.7 million, up 33% year on year, exceeding market expectations by 2.4%. Non-GAAP adjusted EPS was $3.84, 10.9% above analysts’ consensus. Net income rose to $50 million, and net debt was $815 million with net leverage of 2.37x, within its 1-3x target range.

Original reporting
Published Jul 30, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 1:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CSW (NYSE:CSW) Beats Q2 CY2026 Sales Expectations — source image
Decision brief

The 30-second read

$CSWBullishMed
01

Why it matters

The key tradable takeaway is the magnitude of the Q2 beat (revenue and adjusted EPS) and the accompanying operating margin improvement, which can influence near-term positioning and expectations for the next quarters.

02

Market read

A concrete earnings beat with margin improvement typically supports positive near-term price action and can reset short-term expectations for industrials specialty chemical names.

03

What to watch

Net debt is $815M and leverage is 2.37x; if acquisitions drive growth, traders may scrutinize integration risk and whether margin gains are sustainable.

Relevance 8/10Novelty 6/10Timing: post-Q2 results, immediately after-hours/next-session reaction

Background

CSW is an industrial products/specialty chemicals company reporting Q2 CY2026 results with growth driven by acquisitions and organic expansion.

Company-level read

Ticker impact

$CSWBullishMedium confidence
Context

CSW reported Q2 CY2026 revenue up 33% to $350.7M and non-GAAP EPS of $3.84, beating consensus estimates.

Expected impact

Likely supports continued upside follow-through versus peers, though magnitude depends on whether guidance and margins hold.

Evidence & confidence

The article provides concrete beat figures (revenue and adjusted EPS) plus operating margin expansion and net leverage within stated targets, which typically sustains post-earnings sentiment.

Market effects

A strong industrials earnings print with margin expansion can modestly improve sentiment toward industrial chemical/coatings peers.

Primarily US-focused sentiment given NYSE-listed issuer and Wall Street estimate context.

Limited direct global spillover indicated; impacts are mostly within industrials/chemicals sentiment.

Counterpoint

The article highlights a beat but does not provide detailed forward guidance beyond analyst expectations, so the stock may fade if the market demands stronger outlook.

Key entities

  • CSW

    Industrial products company reporting Q2 CY2026 revenue and non-GAAP EPS beats, with operating margin expansion and leverage within target range.

Related articles

$CSWHighAI 9/10

CSW (CSW) Q1 Earnings Report Preview: What To Look For

CSW (NYSE: CSW) is set to report Q1 earnings Tuesday before market open. The company missed revenue and adjusted operating income estimates last quarter, with revenue of $233 million (+20.3% YoY). For Q1, analysts expect revenue up 31.8% YoY. CSW’s average analyst price target is $322.71 versus a $281.22 share price.

$MMIMed

Marcus & Millichap Q2 Earnings Call Highlights

Marcus & Millichap (NYSE: MMI) reported Q2 financing revenue up 15% to $30 million, with transaction count up 17% to 480 and financing dollar volume up 5% to $4 billion. For the first half, financing revenue rose 29% to $57 million. Operating expenses rose to $201 million. Cash equivalents and marketable securities were $345 million. The board declared a $0.25 semiannual dividend and authorized further share repurchases.

$MOSMed

Mosaic Q2 Earnings Call Highlights

Mosaic (NYSE:MOS) said Q2 U.S. phosphate application was nearly 15% below normal and could drop another 20% in 2027. In Brazil, it expects phosphate nutrient application to fall about 30% in 2024 after normal levels in 2023, citing yield pressure. Mosaic guided Q3 sulfur costs $700-$710/ton, ammonia $610-$620, DAP FOB $820-$840, and Q3 phosphate sales 1.1-1.4M tons.

$MPMed

MP Materials Q2 Earnings Call Highlights

MP Materials (NYSE:MP) said it expects Q3 NdPr oxide production to exceed 1,000 metric tons as reliability and throughput improve. It forecasts NdPr oxide realized prices in the high-$90s/kg and PPA income around $10/kg, with flattish sales volume. The company reported mechanical completion of a heavy rare-earth circuit, a nine-figure gadolinium oxide supply deal, and $230.3M Q2 capex. Cash was $1.45B; capex guidance $500M-$600M.